Neither doxycycline nor azithromycin is universally stronger. Each one outperforms the other depending on the infection being treated. For chlamydia and Lyme disease, doxycycline is now the preferred choice. For pneumonia in hospitalized patients, azithromycin has shown better outcomes. The answer depends entirely on what you’re taking it for.
How They Work Differently
Both antibiotics slow bacterial growth by blocking bacteria from making proteins they need to survive. Neither one directly kills bacteria outright. Instead, they stall the infection long enough for your immune system to clear it. Despite this shared strategy, they target different parts of the bacterial machinery, which is why they don’t work equally well against the same bugs.
The biggest practical difference is how long each drug stays active in your body. Azithromycin has a half-life of about 68 hours, meaning it lingers in your tissues for days after your last dose. That’s why it can be prescribed as a single dose or a short three-to-five day course. Doxycycline clears your system much faster and typically needs to be taken twice a day for seven days or longer.
Chlamydia: Doxycycline Is Now First Choice
This is the comparison most people are searching for. The CDC’s current treatment guidelines list doxycycline (taken twice daily for seven days) as the recommended regimen for chlamydia in adolescents and adults. Azithromycin, once the go-to because of its convenient single dose, has been downgraded to an alternative option.
The shift happened because real-world data showed doxycycline produced more reliable cure rates. Azithromycin’s single-dose convenience was appealing, but it left more room for treatment failure, particularly for rectal chlamydia infections. If you’ve been prescribed doxycycline for chlamydia, it’s because the evidence now favors it over azithromycin for this specific infection.
Mycoplasma Genitalium: A Resistance Problem
For Mycoplasma genitalium, a sexually transmitted infection that’s increasingly on clinicians’ radar, azithromycin resistance has become a serious concern. Molecular markers for macrolide resistance (the drug class azithromycin belongs to) range from 44% to 90% in the United States, Canada, Western Europe, and Australia. That means in many cases, azithromycin simply won’t work.
Even more troubling, treating a susceptible infection with a single dose of azithromycin can itself push the bacteria toward resistance, with resistant strains emerging in 10% to 12% of cases. This is one infection where azithromycin’s convenience comes at a real cost. Current guidelines now recommend testing for resistance markers before choosing an antibiotic for this particular STI.
Pneumonia: Azithromycin Has the Edge
For community-acquired pneumonia, the picture flips. A large matched study of more than 5,300 hospitalized patients found that those treated with azithromycin-based regimens had 29% lower in-hospital mortality compared to those on doxycycline-based regimens. The benefits held up over time: 30-day mortality was 15% lower and 90-day mortality was 17% lower in the azithromycin group. Azithromycin-treated patients also spent roughly 1.4 fewer days in the hospital.
This doesn’t mean doxycycline is useless for respiratory infections. It remains a reasonable option for mild cases, bronchitis, and situations where azithromycin isn’t tolerated. But when pneumonia is serious enough to require hospitalization, azithromycin appears to be the stronger performer.
Lyme Disease: Doxycycline Is Preferred
For early Lyme disease, doxycycline is one of three first-line options recommended by the CDC, alongside amoxicillin and cefuroxime. Azithromycin is reserved only for people who can’t tolerate any of those three, and the CDC specifically notes it is “less effective.” Patients treated with azithromycin for Lyme disease need closer monitoring to make sure symptoms actually resolve.
Doxycycline also has a unique advantage for tick-borne illness: it’s effective against several other infections ticks can carry simultaneously, making it a practical choice when you’re not sure exactly what the tick transmitted.
Side Effects and Tolerability
The side effect profiles are almost mirror images of each other. Azithromycin hits the gut harder. In user-reported data, about 31% of azithromycin users experienced diarrhea, 24% had nausea, and 15% reported upset stomach. Doxycycline caused nausea in about 20% of users, but diarrhea was much less common at just 3%.
Doxycycline comes with its own drawbacks that don’t show up in those numbers. It makes your skin significantly more sensitive to sunlight, so sunburns happen faster and more severely. It can also cause painful irritation of the esophagus if you take it without enough water or lie down too soon after swallowing it. Taking it with food and a full glass of water, then staying upright for at least 30 minutes, prevents most of that discomfort. Azithromycin has no sun sensitivity issues and is gentler on the esophagus.
For people who struggle with a seven-day course, azithromycin’s shorter regimen (sometimes just a single dose) can be easier to complete. Finishing the full course matters, because stopping early contributes to antibiotic resistance and raises the chance the infection comes back.
Which One You’ll Likely Be Prescribed
Your prescription will depend on the infection, not on which drug is broadly “stronger.” Here’s a simplified breakdown:
- Chlamydia: Doxycycline is the current first-line recommendation.
- Pneumonia: Azithromycin is generally preferred, especially for moderate to severe cases.
- Lyme disease: Doxycycline is a first-line option; azithromycin is a backup.
- Sinus and ear infections: Azithromycin is commonly prescribed for its convenience, though doxycycline can also be used.
- Acne and skin conditions: Doxycycline is the more common choice due to its effectiveness against skin bacteria and its anti-inflammatory properties.
If you’ve been prescribed one and are wondering whether the other would work better, the short answer is that your provider likely chose based on which drug has the stronger track record for your specific infection. These two antibiotics aren’t interchangeable, and the “stronger” one changes depending on what it’s fighting.